Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R B Raffa

Showing results (31-40 of 175) with videos related to

Pageof 18
Sort By:
Life Sciences|January 1, 1992
Receptor regulation, competitive antagonism and pA2R J Tallarida, R B Raffa
Brain Research|April 24, 1995
The 'glibenclamide-shift' of centrally-acting antinociceptive agents in miceR B Raffa, R P Martinez
Brain Research|July 4, 1994
Lack of glibenclamide or TEA affinity for opioid receptors: further evidence for in vivo modulation of antinociception at K+ channelsR B Raffa, E E Codd
The Journal of Pharmacology and Experimental Therapeutics|September 1, 1990
Effect of Phe-D-Met-Arg-Phe-NH2 and other Phe-Met-Arg-Phe-NH2-related peptides on mouse colonic propulsive motility: a structure-activity relationship studyR B Raffa, H I Jacoby
Life Sciences|January 1, 1991
Centrally-mediated antinociceptive action of RWJ-22757 (formerly McN-5195): involvement of spinal descending inhibitory pathways (an hypothesis)J L Vaught, R B Raffa
Peptides|May 1, 1989
FMRFamide enhances acetylcholine-induced contractions of guinea pig ileumR B Raffa, H I Jacoby
Life Sciences|January 1, 1997
An examination of the relationship between mu-opioid antinociceptive efficacy and G-protein coupling using pertussis and cholera toxinsT L Goode, R B Raffa
Journal of Clinical Pharmacy and Therapeutics|March 3, 2015
Delta opioid agonists: a concise update on potential therapeutic applicationsJ F Peppin, R B Raffa
Neuropeptides|July 1, 1992
Supraspinal antinociception produced by [D-Met2]-FMRFamide in miceR B Raffa, C D Connelly
Neuroreport|July 10, 1995
Antinociceptive defect of beige-J mice reversed by i.c.v. IP3 or myo-inositolR B Raffa, R P Martinez
Pageof 18

Showing results (31-40 of 175) with videos related to

Sort By:
Pageof 18
Life Sciences|January 1, 1992
Receptor regulation, competitive antagonism and pA2R J Tallarida, R B Raffa
Brain Research|April 24, 1995
The 'glibenclamide-shift' of centrally-acting antinociceptive agents in miceR B Raffa, R P Martinez
Brain Research|July 4, 1994
Lack of glibenclamide or TEA affinity for opioid receptors: further evidence for in vivo modulation of antinociception at K+ channelsR B Raffa, E E Codd
The Journal of Pharmacology and Experimental Therapeutics|September 1, 1990
Effect of Phe-D-Met-Arg-Phe-NH2 and other Phe-Met-Arg-Phe-NH2-related peptides on mouse colonic propulsive motility: a structure-activity relationship studyR B Raffa, H I Jacoby
Life Sciences|January 1, 1991
Centrally-mediated antinociceptive action of RWJ-22757 (formerly McN-5195): involvement of spinal descending inhibitory pathways (an hypothesis)J L Vaught, R B Raffa
Peptides|May 1, 1989
FMRFamide enhances acetylcholine-induced contractions of guinea pig ileumR B Raffa, H I Jacoby
Life Sciences|January 1, 1997
An examination of the relationship between mu-opioid antinociceptive efficacy and G-protein coupling using pertussis and cholera toxinsT L Goode, R B Raffa
Journal of Clinical Pharmacy and Therapeutics|March 3, 2015
Delta opioid agonists: a concise update on potential therapeutic applicationsJ F Peppin, R B Raffa
Neuropeptides|July 1, 1992
Supraspinal antinociception produced by [D-Met2]-FMRFamide in miceR B Raffa, C D Connelly
Neuroreport|July 10, 1995
Antinociceptive defect of beige-J mice reversed by i.c.v. IP3 or myo-inositolR B Raffa, R P Martinez
Pageof 18